Hotspot Therapeutics

Boston, United States · Founded 2017 · $210.0M raised

Headquarters
Boston
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$210.0M
Last Round
$45.0M Series ANov 2021
Rounds
3

About

HotSpot Therapeutics is a clinical-stage biotech company pioneering allosteric drug discovery through its Smart Allostery platform, which identifies natural regulatory hotspots on proteins remote from the active site. Founded in 2017 by Jonathan Montagu and Geraldine Harriman in Cambridge, Massachusetts, the company is developing novel small-molecule therapies for cancer and autoimmune diseases including lupus.

Summary

Hotspot Therapeutics is a Biotech company based in Boston, United States, founded in 2017. It has raised $210.0M in total across 3 rounds, most recently a $45.0M Series A round in Nov 2021.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CNov 2021
$100.0M

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hotspot Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/hotspot-therapeutics"><img src="https://indexed.vc/api/badge/company/hotspot-therapeutics" alt="Hotspot Therapeutics on Indexed.vc" width="260" height="76" /></a>